Skip to main content

Information updates

Due date extended to 8 May 2024 - Call for EOIs from ASCIA Members for Allergy Education and Training Initiatives

ASCIA is facilitating education and training initiatives to upskill health professionals, as part of the National Allergy Council Shared Care for Allergy project.

ASCIA is now inviting Expressions of Interests (EOI) from ASCIA members for funding of initiatives that improve access and timely delivery of allergy education and training for health professionals.

An EOI  form to complete is available here. docxASCIA EOI Form 2024123.16 KB

EOIs should be no longer than four pages, excluding attachments (CV and budget details). Please email completed EOIs to This email address is being protected from spambots. You need JavaScript enabled to view it. by 8 May 2024.

The allergy education/training initiative in your EOI should meet the following criteria:

  • Provide standardised, evidence-based and best practice postgraduate allergy education and training for one or more of the following health professions;
    • General Practitioners
    • Paediatricians
    • Other Medical Practitioners (other than clinical immunology/allergy specialists and trainees)
    • Dietitians
    • Nurses
    • Pharmacists
    • Psychologists
  • Improve access to postgraduate allergy education and training for health professionals, including those in regional, rural and remote areas
  • Have a budget of $10,000 up to $100,000 AUD per initiative
  • Be piloted within 12 months (by the end of 2025)
  • Have the potential to be scaled up
  • Have measurable outcomes
  • Involve at least one Full ASCIA member 

Important Dates

  • Call for EOIs open: 14 March 2024
  • Call for EOIs close: 8 May 2024
  • Funding awarded: July 2024

We look forward to receiving your EOIs.

Kind regards,

A/Professor Theresa Cole
ASCIA President
Jill Smith
This news item was issued on 14 March 2024 and updated on 19 April 2024 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.